Microencapsulated G3C Hybridoma Cell Graft Delays the Onset of Spontaneous Diabetes in NOD Mice by an Expansion of Gitr+ Treg Cells
- 13 March 2020
- journal article
- research article
- Published by American Diabetes Association in Diabetes
- Vol. 69 (5), 965-980
- https://doi.org/10.2337/db19-0087
Abstract
As an alternative to lifelong insulin supplementation, potentiation of immune tolerance in patients with type 1 diabetes could prevent the autoimmune destruction of pancreatic islet β-cells. This study was aimed to assess whether the G3c monoclonal antibody (mAb), which triggers the glucocorticoid-induced TNFR-related (Gitr) costimulatory receptor, promotes the expansion of regulatory T cells (Tregs) in SV129 (wild-type) and diabetic-prone NOD mice. The delivery of the G3c mAb via G3C hybridoma cells enveloped in alginate-based microcapsules (G3C/cps) for 3 weeks induced Foxp3+ Treg-cell expansion in the spleen of wild-type mice but not in Gitr−/− mice. G3C/cps also induced the expansion of nonconventional Cd4+Cd25−/lowFoxp3lowGitrint/high (GITR single-positive [sp]) Tregs. Both Cd4+Cd25+GitrhighFoxp3+ and GITRsp Tregs (including also antigen-specific cells) were expanded in the spleen and pancreas of G3C/cps-treated NOD mice, and the number of intact islets was higher in G3C/cps-treated than in empty cps-treated and untreated animals. Consequently, all but two G3C/cps-treated mice did not develop diabetes and all but one survived until the end of the 24-week study. In conclusion, long-term Gitr triggering induces Treg expansion, thereby delaying/preventing diabetes development in NOD mice. This therapeutic approach may have promising clinical potential for the treatment of inflammatory and autoimmune diseases.Keywords
This publication has 53 references indexed in Scilit:
- Modulation of Treg cells/T effector function by GITR signaling is context–dependentEuropean Journal of Immunology, 2013
- Long-Term Metabolic and Immunological Follow-Up of Nonimmunosuppressed Patients With Type 1 Diabetes Treated With Microencapsulated Islet AllograftsDiabetes Care, 2011
- CD4+CD25lowGITR+ cells: A novel human CD4+ T‐cell population with regulatory activityEuropean Journal of Immunology, 2011
- Reversal of hyperglycemia in diabetic mouse models using induced-pluripotent stem (iPS)-derived pancreatic β-like cellsProceedings of the National Academy of Sciences of the United States of America, 2010
- Reversal of Autoimmunity by Boosting Memory-like Autoregulatory T CellsImmunity, 2010
- GITR engagement preferentially enhances proliferation of functionally competent CD4+CD25+FoxP3+ regulatory T cellsInternational Immunology, 2010
- Antigen-Specific Dependence of Tr1-Cell Therapy in Preclinical Models of Islet TransplantDiabetes, 2009
- Therapy of experimental type 1 diabetes by isolated Sertoli cell xenografts aloneThe Journal of Experimental Medicine, 2009
- GITR/GITRL: More than an effector T cell co‐stimulatory systemEuropean Journal of Immunology, 2007
- Role of GITR in activation response of T lymphocytesBlood, 2002